Cabergoline Tablets Category
Cabergoline Overview
Cabergoline is a category centred on tablet-based listings identified by the stated substance name cabergoline, with common brand references in the market including Dostinex and Cabaser where shown on the original packaging. Within this section, the main points of comparison are usually the listed strength per tablet, the number of tablets in the pack, and the manufacturer or brand shown in the product title.
As part of the broader Post Cycle Therapy catalogue structure on this site, Cabergoline listings can vary noticeably in presentation. Some entries are shown with strengths such as 0.125 mg, 0.25 mg, 0.5 mg, 1 mg or 2 mg, while pack formats may differ between shorter and larger tablet counts. For that reason, accurate comparison depends on checking the full product title and packaging details rather than relying on name alone.
What to Compare
When reviewing Cabergoline listings, the first specification to check is the stated strength per tablet. A title that includes 0.25 mg, 0.5 mg, 1 mg or 2 mg is referring to the amount listed for each tablet, not for the full pack. This matters because products in this category may look similar at a glance while representing different strengths and different total tablet counts.
The second point is pack presentation. Some products are listed as 8 tablets, 10 tablets or 20 tablets, depending on the manufacturer. This should always be read as pack quantity, separate from tablet strength. If a listing includes both a numerical strength and a tablet count, compare them together so the specification is clear.
Brand and manufacturer are also important for identification. Verified names shown in the category data include Pfizer, Intex Pharma UK, Evolve Biolabs INT, Hilma Biocare EU, Apical Pharma, Deus Medical, Driada Medical EU, XT Labs USA, Beligas Pharma USA and Ultima Pharma USA. Brand naming can differ even when the stated substance remains the same, so the label name, logo style, print quality and full product wording on the packaging can all help distinguish one listing from another.
Another useful comparison point is naming convention. Some listings are presented directly as Cabergoline, while others appear under branded references such as Cabaser, Dostinex, CABERMED, DOSINTEXT or ULTIMA-CABER. These naming differences do not replace the need to verify the stated substance and the exact strength shown on the listing.
- Check the stated strength per tablet, not just the product name.
- Confirm the tablet count shown in the pack presentation.
- Compare manufacturer and brand naming carefully.
- Review whether the listing uses a generic or branded product title.
- Use the packaging details and printed specifications for final verification.
Technical Overview
Based on the verified category data available, Cabergoline products in this category are presented primarily in tablet form. The listed range includes multiple strengths and several branded presentations, which makes this a specification-led category rather than one that can be understood from a single standard format.
- Category
- Cabergoline
- Parent category
- Post Cycle Therapy
- Common listed form
- Tablets
- Verified strength examples
- 0.125 mg, 0.25 mg, 0.5 mg, 1 mg, 2 mg
- Verified pack examples
- 8 tablets, 10 tablets, 20 tablets
- Known brand references in supplied data
- Dostinex, Cabaser, CABER, Caberbol, CABERMED, Caberos, DOSINTEXT, Pro-Dostinex, ULTIMA-CABER
- Verified manufacturers in supplied data
- Pfizer, Intex Pharma UK, Evolve Biolabs INT, Hilma Biocare EU, Apical Pharma, Deus Medical, Driada Medical EU, XT Labs USA, Beligas Pharma USA, Ultima Pharma USA
Because the category includes multiple label styles and naming formats, technical comparison should focus on the printed details that remain consistent across product references: substance name, strength, tablet count, and manufacturer identity. If two listings appear close in name but differ in one of these points, they should be treated as separate specifications.
It is also worth checking whether a product title includes additional wording such as Lite, Pro, IP or a house-brand code. These terms can indicate a particular branded presentation, but they do not replace the core identifiers. The most reliable product reference remains the combination of stated substance, strength per tablet, quantity and brand.
Safety and Verification
For this category, careful packaging review is important. Compare the outer box and blister details with the listing title, especially where a product is sold under a brand reference rather than simply under the substance name. Batch information, print consistency, spelling, logo placement and sealed packaging can all help with identification.
Retain the packaging for verification. If a listing includes a known manufacturer name, check that the branding on the item and outer packaging matches the same manufacturer reference. Differences in strength, pack size or wording should be reviewed before relying on the product reference.
Store according to the information printed on the original packaging. If any detail on receipt does not match the listing title, such as a different tablet count, different strength or different branded presentation, the product reference should be checked against the packaging before further handling.
As with similar sensitive-product categories, this page is intended for neutral comparison of listing information. It is not a substitute for medical, treatment or personal handling advice, and the category should be read as a reference point for specification checks, packaging review and product distinction.
Related Categories
Featured Brands
- Apical Pharma
- Beligas Pharma USA
- Deus Medical
- Driada Medical EU
- Evolve Biolabs INT
- Hilma Biocare EU
- Intex Pharma UK
- Pfizer
- Ultima Pharma USA
- XT Labs USA
Frequently Asked Questions
- What is the main difference between Cabergoline listings in this category?
- The main differences are usually the stated strength per tablet, pack quantity, and the manufacturer or brand shown in the product title and packaging.
- Are Dostinex and Cabaser the same as Cabergoline?
- They are brand references associated with cabergoline in the supplied category data. The exact listing should still be checked for strength, tablet count and manufacturer details.
- How should strength information be read on these listings?
- Strength values such as 0.25 mg or 0.5 mg should be read as the amount stated for each tablet unless the listing clearly says otherwise.
- Why do some products have different names if they contain the same stated substance?
- Manufacturers and brands may use different product names, house labels or branded presentations. The most reliable comparison points are the substance name, printed strength, pack size and manufacturer identity.
- What should be checked when the product arrives?
- Compare the packaging, label wording, tablet count, strength and manufacturer details against the listing title. Retain the packaging for verification.
- How should Cabergoline products be stored?
- Store according to the information printed on the original packaging.